EXAGEN INC. (XGN) › Operating Cash FlowEXAGEN INC. (XGN) — Operating Cash FlowAnnual figures by period end, from SEC filings.2018-12-31: -$9.30M2019-12-31: -$9.71M2020-12-31: -$14.08M2021-12-31: -$20.27M2022-12-31: -$32.14M2023-12-31: -$14.46M2024-12-31: -$13.28M2025-12-31: -$13.62M-$13.62M2018-12-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31-$13.62M—2026-03-10From 2025-01-012024-12-31-$13.28M—2026-03-10From 2024-01-012023-12-31-$14.46M—2025-03-11From 2023-01-012022-12-31-$32.14M—2024-03-18From 2022-01-012021-12-31-$20.27M—2023-03-20From 2021-01-012020-12-31-$14.08M—2022-03-22From 2020-01-012019-12-31-$9.71M—2021-03-16From 2019-01-012018-12-31-$9.30M—2020-03-25From 2018-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)